Fibrillary glomerulonephritis: an observational study of clinical-pathological features and outcomes in patients from

Jean Patrick1, Madeline Charles-Rudwick1, Charlotte Quinn2

  • 1Department of Renal Medicine, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK.

PubMed
Abstract

Insights

Fibrillary glomerulonephritis (FGN) has poor renal outcomes. Female sex, proteinuria, and diffuse proliferative glomerulonephritis (DPGN) predict end-stage renal disease (ESRD) progression in FGN patients.

Area of Science:

  • Nephrology
  • Pathology

Background:

  • Fibrillary glomerulonephritis (FGN) is a rare kidney disease characterized by abnormal fibril deposition.
  • It is associated with poor renal outcomes and lacks specific treatments.
  • Identifying predictors of FGN progression is crucial for patient management.

Purpose of the Study:

  • To identify clinical and pathological predictors of outcomes in patients with FGN.
  • To analyze a multi-institutional cohort with centralized histopathology review.

Main Methods:

  • Retrospective analysis of 35 patients with biopsy-proven FGN (2015-2024).
  • Clinical data, comorbidities, laboratory parameters, and outcomes were collected.
  • Histological characteristics and DNAJB9 staining were analyzed.

Main Results:

  • The cohort had a mean age of 62.8 years, with a 2.8:1 female-to-male ratio.
  • Common comorbidities included diabetes mellitus (34.2%) and malignancy (20%).
  • 51% progressed to end-stage renal disease (ESRD) within a median of 39 months. Female sex, proteinuria, and diffuse proliferative glomerulonephritis (DPGN) were significant predictors of ESRD.

Conclusions:

  • FGN is linked to malignancy, autoimmune disease, and diabetes mellitus.
  • Prognosis for FGN remains poor.
  • Proteinuria, DPGN, and female sex significantly influence progression to ESRD.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
33
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
24
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
47
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
59
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104